RxDoctor Payments Data

Raymond Peters, MD

Family Medicine · Enon, OHNPI 1346223351

Payments from drug & device makers

$1,324in general payments, 2019–2025

Across 63 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$256
  • Lilly USA, LLC$221
  • AbbVie$169
  • Boehringer Ingelheim$147
  • Pfizer$138
  • Johnson & Johnson$76
  • plus $316 from 11 others

What the payments were for

  • Food & beverage$1,31599%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,324 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$40,561
Medicare patients
102
Services billed
506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin92$123,271
EliquisApixaban56$71,244
FarxigaDapagliflozin Propanediol26$40,840
OzempicSemaglutide39$38,425
MounjaroTirzepatide30$37,560
TrulicityDulaglutide23$30,149
JanuviaSitagliptin Phosphate26$29,946
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$26,012
Spiriva RespimatTiotropium Bromide27$25,805
XareltoRivaroxaban17$24,490
MyrbetriqMirabegron21$21,523
Breo ElliptaFluticasone/Vilanterol25$17,704
Repatha SureclickEvolocumab16$15,048
Repatha SyringeEvolocumab11$7,014
TrintellixVortioxetine Hydrobromide13$6,867

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$147$149,076119 claims
PfizerEliquis$138$71,24456 claims
Lilly USA, LLCMounjaro, Trulicity$221$67,70953 claims
AstraZenecaFarxiga, Symbicort$256$46,02845 claims
GSKTrelegy Ellipta, Breo Ellipta$31$43,71647 claims
Novo NordiskOzempic$45$38,42539 claims
MerckJanuvia$13$29,94626 claims
Johnson & JohnsonXarelto$76$24,49017 claims
Astellas Pharma US IncMyrbetriq$75$21,52321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Enon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →